GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Vendor] QSC vs Homopeptide on the same compound, same month — both cleared 98.5% — 26 comments in the full submission. View in context.
6.2k
c/retatrutide·submitted 1 year ago by u/baseline_drifter

[Vendor] QSC vs Homopeptide on the same compound, same month — both cleared 98.5%

Questionbranch of 7 comments

Numbers in the title, numbers in the post. QSC vs Homopeptide on the same compound, same month — both cleared 98.5%. Figures up front so nobody has to dig: 98.5%. Sent a vial to VendorInvestigate out of curiosity. Result was 98.0% against a claimed 97.5%, which is the first independent number I had seen for this…

Read the full submission and all 26 comments →

This branch

7 comments, started 1 year ago
u/reflux_report177 points·1 year ago

dose escalation in the trials was slow for a reason

replysharereportpermalink
u/yusuf_ramos45 points·1 year ago

a lot of the confident posting here is extrapolation

replysharereportpermalink
u/solene_ilunga29 points·1 year ago

That reads as a titration plan for an unapproved compound. This board cannot host that and it should not want to.

replysharereportpermalink
u/yusuf_ramos17 points·1 year ago

Has anyone posted an independent test on this compound recently?

replysharereportpermalink
u/reflux_report4 points·1 year ago

research-use-only material is not approved for human use, full stop

replysharereportpermalink
u/careful_gradient3212 points·1 year ago

phase 2 data only, and people quote it like it is a label

replysharereportpermalink
u/careful_gradient_notes112 points·1 year ago

Correction: TRIUMPH is the phase 3 programme. The number you are quoting is from the phase 2 readout, which is a different trial.

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/retatrutide
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/reta_and_regretu/trialwatch_theou/incretin_ivyu/ledger_mod
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →